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as a N-terminal His 6 fusion. The inserted pbp4[Y21-Q383] gene was confirmed by sequencing (Genewiz or Beckman Sequencing Facility). E. coli novablue strain was used for cloning.
The catalytic serine residue (S75) of the transpeptidase domain of S. aureus PBP4 has been identified by sequence alignment with other PBPs. 5 The S75A mutation was made in the parent plasmid pPBP4[Y21-Q383] using techniques described in the QuickChange site-directed mutagenesis kit (Stratagene) to make the mutant plasmid pPBP4[Y21-Q383] S75A with the forward primer 5'-CTAAGTGGAATCCAGCGGCAATGACTAAATTAATGAC-3' and the reverse primer 5'-GTCATTAATTTAGTCATTGCCGCTGGATTCCACTTAG-3' (mutagenized codon is underlined).
Overexpression and purification of S. aureus PBP4[Y21-Q383] and PBP4[Y21-Q383] S75A mutant
Plasmid pPBP4[Y21-Q383] encoding for soluble S. aurues PBP4 and plasmid pPBP4[Y21-Q383] S75A encoding for S. aureus PBP4 TP* were collected from the cloning strains, and were transformed into E. coli BL21(DE3) cultures respectively for overexpression and purification. E. coli BL21 (DE3) cultures (LB medium supplemented with 50 µg/ mL kanamycin) were used to inoculate 1 L of LB medium (1:100) supplemented with 50 µg/mL kanamycin at 37 °C and grown to OD 600 = 0.4-0.5 with shaking. Cells were cooled to 17 °C before induction with 0.5 mM IPTG for 17 hr with shaking. Cells were harvested by centrifugation (5250 x g, 20 min, 4 °C) and pellets were resuspended on ice with 30 mL of Buffer A (20 mM Tris (pH = 7.5), 400 mM NaCl) with 1 mM phenylmethylsulfonyl fluoride (PMSF). Cells were lysed by three passages through a cell disrupter ( 
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Bocillin-FL binding assay to ensure proper folding of TP domain of purified PBP4 protein Purified S. aureus PBP4 protein (250 nM) was incubated with varying concentrations of penicillin G (penG) (1000, 100, 0 U/mL) in a buffer containing 20 mM potassium phosphate (pH = 7.5) and 140 mM NaCl (to reach a volume of 9 µL). The mixture was incubated at 37 °C for 1 hr with shaking. Bocillin-FL (1 µL of 100 µM stock) was added to the mixture (total reaction volume is 10 µL), 6 which was then incubated for 30 min at 37 °C with shaking. The reaction was quenched by adding 2x SDS loading dye, and heated for 20 min at 95 °C. The samples were loaded onto a SDS-PAGE gel, which was then scanned using Typhoon (fluorescence scan, excitation 488 nm, emission 526 nm). The scanned image was then analyzed using ImageJ (Figure S1 ).
LC/MS assay to evaluate PBP4 TP activity in vitro
The procedure was modified from our recent report. 1b Lys-Lipid II (40 µM) was incubated with SgtB (1 µM) and PBP4 (2 µM) in reaction buffer (12.5 mM HEPES (pH = 7.5), 2 mM MnCl 2 , 20% DMSO, and 250 µM Tween-80) in a total of 10 µL reaction volume for 1 hr at 25 °C in the absence or presence of glycine oligopeptides or various D-amino acids (all solutions were used at 1 mM; except for Gly 3 and Gly 5 solutions that were acidified with 0.01 N HCl to facilitate solubility, and were used at a final concentration of 5 mM). The reaction was quenched at 95 °C for 5 min, and then treated with mutanolysin (from Streptomyces globisporus, Sigma, 1 U) for 1.5 hr at 37 °C followed by another 1 U aliquot for 1.5 hr. The resulting disaccharides were reduced with sodium borohydride (10 mg/mL, 30 min) to resolve the MurNAc anomers. Phosphoric acid (20%, 1.2 µL) was then added to adjust the pH to ~4. The reaction mixture was the lyophilized, redissolved in 12 µL H 2 O and subjected to LC/MS analysis, conducted with ESI-MS operating in positive mode. The instrument was equipped with a Waters Symmetry Shield RP18 column (5 µM, 3.9 x 150 mm) with a matching column guard.
The fragments were separated using the following method: 0.5 mL/min H 2 O (0.1% formic acid) for 5 min followed by a gradient of 0% acetonitrile (ACN) (0.1% formic acid)/H 2 O (0.1% formic acid) to 20% ACN (0.1% formic acid)/H 2 O (0.1% formic acid) over 40 min. Molecular ions corresponding to expected disaccharide fragments were extracted from chromatograms (Figure 1 and S2) .
To analyze the ability of PBP4 to use polymeric PG and monomeric Lipid II as substrates, the above procedure is modified slightly. To analyze PBP4 activity on preformed PG polymer, Lys-Lipid II (40 µM) was incubated with SgtB (1 µM) for 1 hr at 25 °C, prior to inactivation of SgtB at 95 °C for 5 min. PBP4 (2 µM) and D-Tyr (1 S5 mM) were added to the reaction mixture which was incubated for another hour at 25 °C before heat quenching.
The digestion procedure is identical to above. To analyze PBP4 activity on Lipid II monomer, Lys-Lipid II (40 µM) was incubated with PBP4 (2 µM) and D-Tyr (1 mM) for 1 hr at 25 °C, prior to inactivation of PBP4 at 95 °C for 5 min. SgtB (1 µM) was added to the reaction mixture which was incubated for another hour at 25 °C before heat quenching. The digestion procedure is identical to above. Molecular ions corresponding to the expected disaccharide fragments were extracted from chromatograms (Figure 4 and S4a). To analyze PBP4 activity to exchange unnatural D-amino acids into Lipid II monomers, the respective D-amino acid substrates were used instead of D-Tyr using the same protocol ( Figure S4b) .
Microscopy imaging analysis of FDL labeling in S. aureus strains
S. aureus strains (MW2 wildtype, ∆pbp4, and ∆pbp4 complemented with pbp4 gene) 4 were grown for 4 hr in TSB at 37 °C to stationary phase. The cultures were then diluted to reach OD 600 = 0.1 and allowed to grow for an additional 30 min to reach mid-log phase. To 0.5 mL of S. aureus culture, 1 µL of FDL probe (2 mM in DMSO) was added (giving a final concentration of 4 µM). The cultures were incubated briefly for 10 min at 37 °C with shaking, and fixed with ice cold 70% ethanol immediately. The fixed cells were then incubated on ice for 15 min, before washing with PBS buffer for three times. The washed cell pellet was resuspended in 30 µL PBS, and 2 µL liquid was mounted on PBS pads containing 2% agarose. The samples were imaged using BODIPY-GFP channel. Images were adjusted to the same intensity scale to allow comparison using ImageJ. 7
Deprotection of BDL probe
To Fmoc-D-Lys(biotinyl)-OH (0.016 mmol, 10 mg) in a glass vial, 2 mL of 20% piperidine/DMF and 0.3 mL toluene were added. The mixture was stirred to dissolve for 30 min at room temperature, and then concentrated to remove solvent in vacuo. The crude concentrated mixture was diluted in H 2 O leaving a white byproduct precipitate, which was removed via filtration. The filtrate was concentrated, and the product was analyzed by MS direct injection in positive mode. Pure BDL probe was prepared as a stock solution of 10 mM in H 2 O.
Preparation of Lipid I and Lipid II analogs with functionalized D-amino acids by PBP4
An aliquot of C20-Lys-Lipid I analog (50 nmol) in DMSO (20 µL) 1c,8 was briefly sonicated and then diluted with 20 µL of 10x reaction buffer (125 mM HEPES pH = 7.5, 20 mM MnCl 2 , and 2.5 mM Tween-80). Biotinylated D-S6 Lysine (BDL) (5mM, final concentration) and PBP4 (20 µM, final concentration) were then added to the reaction mixture to reach a final volume of 200 µL. The reaction was incubated for 3 hr at 25 °C, and then kept on ice before purification. The reaction mixture was loaded onto a pre-equilibrated Strata C18-E SPE column (Phenomenex), then eluted with ACN/25 mM NH 4 HCO 3 using a step gradient of 0% to 100% ACN (500 µL each, 10% increment). The collected fractions were analyzed by MS direct injection in negative mode. The modified-Lipid I analog was eluted in 30%-40% ACN fractions. HRMS data was obtained for the fractions contain pure BDL-incorporated Lipid I analog (Figure S5) . D-propargylglycine (DPG)-modified Lipid I analog was obtained using DPG in place of BDL following the same protocol (Figure S5) .
The fractions that contained pure BDL-incorporated Lipid I analog were combined and concentrated by speedvac. Lipid I to Lipid II conversion was carried out as previously described. 9 Briefly, the dried Lipid I analog (50 nmol) was re-dissolved in MeOH (24 µL analyzed by MS direct injection in negative mode. The modified-Lipid II analog was eluted in the initial MeOH/ 0.1% NH 4 OH fraction (500 µL). HRMS data was also obtained for the pure BDL-modified Lipid II analog (Figure 5a and S5b) . DPG-modified Lipid II analog was converted from DPG-Lipid I following the same protocol. (Figure S5) .
Western blot detection of BDL-Lipid II in vitro
To a non-stick reaction vial, 3 µL H 2 O and 1 µL of 10x reaction buffer (125 mM HEPES pH = 7.5, 20 mM MnCl 2 , and 2.5 mM Tween-80) was added with 3 µL of BDL probe (10 mM in H 2 O). The mixture was vortexed before adding 1 µL of Lys-Lipid II (200 µM in DMSO), 1 µL of DMSO, and 1 µL of PBP4 (40 µM) to reach a total volume of 10 µL. The reaction was incubated at 25 °C for 1 hr. To quench the reaction, 10 µL of 2x SDS loading buffer was added and the samples were heated at 95 °C for 5 min. 3 µL of the final mixture was loaded onto a 15% SDS polyacrylamide gel. The products were transferred to Immun-Blot PVDF membrane (BioRad).
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BDL-Lipid II was detected by blotting with streptavidin-HRP (1:10000 dilution, Pierce), and visualized using ECL Prime Western Blotting Detection Reagent (GE Ambersham) and Biomax Light Film (Kodak). To confirm the presence of PBP4, the membrane was also blotted with anti-His 5 -HRP (1:10000 dilution, Qiagen). Control reactions were performed with omitting one or two components (Figure S6) .
Extraction of cellular lipid-linked PG precursors and western blot detection
The extraction of cellular lipids has been modified from a previously published protocol. 10 An overnight culture of S. aureus RN4220 was diluted to an OD 600 = 0.1, and allowed to grow to mid-exponential phase at 37 ˚C.
The culture was divided into 2 mL aliquots subsequently which were treated with antibiotics (concentrations of antibiotics were about 2x of their respective MICs against S. aureus RN4220, see Figure S8 ). Following 10 min of growth at 37 ˚C, cells were harvested by centrifugation for 10 min at 5,000 x g. The amount of cell pellet collected was normalized by OD 600 , and resuspended in 500 µL PBS (pH 7.4). The resuspended pellet was transferred to a glass tube alongside 500 µL CHCl 3 and 1 mL MeOH. The mixture was vortexed repetitively for 10 min at 25 ˚C, following which any cell debris was removed with centrifugation for 10 min at 4,000 x g. The supernatant was collected and transferred to a new glass tube with 500 µL CHCl 3 and 500 µL PBS. The mixture was vortexed for 10 min, and centrifuged for 1 min at 4,000 x g to achieve phase separation. 1 mL of the organic layer was collected and concentrated in vacuo. The dried fractions were resuspended in 12 µL DMSO. 2 µL of each fraction was used (in place of Lipid II and DMSO) in a BDL labeling reaction as described earlier. Reactions were further analyzed using a western blot with the use of HRP-Conjugated Strepavidin as the antibody (Figure 5b and S7) .
Measurement of minimum inhibitory concentration (MIC) of antibiotic against S. aureus RN4220
A serial dilution of antibiotic was prepared, and 1.5 µL of each was added to a clear 96-well plate (Corning). To each well containing antibiotic, 150 µL of a culture of S. aureus RN4220 at OD 600 = 0.1 (diluted from a saturated overnight culture in TSB medium) was seeded. The plate was shaken at 37 °C and OD 600 reading was taken after 10 hr. The concentration of antibiotic that showed no bacteria growth was designated the MIC. S13 Figure S3 . S. aureus PBP4 shows TP activity in vivo, and is a major pathway for D-amino acid incorporation in S. aureus PG. S. aureus wildtype strain incorporates a fluorescent D-lysine probe (FDL) efficiently, but ∆pbp4 strain shows dramatic decrease in FDL incorporation efficiency. Complementation with pbp4 gene restores the incorporation efficiency (Scale bar: 2 µM). Sample preparation is described above. S14 S15 Figure S4 . PBP4 exchanges D-amino acids in monomeric Lipid II efficiently. (a) Schematic for analysis of PBP4 activity with Lys-Lipid II monomers, which is also described in Figure 4a . Reactions of PBP4 (2 µM) with Lys-Lipid II (40 µM) and D-Tyr (0 µM, 20 µM, 400 µM and 1 mM) were first incubated at room temperature for 30 min before quenching at 95 °C for 5 min to inactivate PBP4. SgtB (1 µM) was then added to the mixture for incubation at room temperature for 1 hr.
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Supplementary figures
Reactions were then digested according to procedures described above. EICs show that the magnitude of peak C 
